BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23523088)

  • 21. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of treatment interruptions in the postoperative irradiation of breast cancer.
    Bese NS; Sut PA; Ober A
    Oncology; 2005; 69(3):214-23. PubMed ID: 16127290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
    Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
    Cho WK; Choi DH; Park W; Kim H; Cha H
    Breast; 2019 Oct; 47():16-21. PubMed ID: 31265973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
    Ringberg A; Idvall I; Fernö M; Anderson H; Anagnostaki L; Boiesen P; Bondesson L; Holm E; Johansson S; Lindholm K; Ljungberg O; Ostberg G
    Eur J Surg Oncol; 2000 Aug; 26(5):444-51. PubMed ID: 11016463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of Surgical Margin Status in Ductal Carcinoma In Situ.
    Shaikh T; Li T; Murphy CT; Zaorsky NG; Bleicher RJ; Sigurdson ER; Carlson R; Hayes SB; Anderson P
    Clin Breast Cancer; 2016 Aug; 16(4):312-8. PubMed ID: 26952595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
    Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
    Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
    J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
    Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
    Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
    Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
    Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy.
    Park S; Park HS; Kim SI; Koo JS; Park BW; Lee KS
    Jpn J Clin Oncol; 2011 May; 41(5):600-8. PubMed ID: 21355001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04).
    Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Ha SW; Kim K; Kim YB; Yea JW; Kang MK; Shin KH; Kim DW; Lee JH; Suh CO
    Breast Cancer Res Treat; 2014 Jul; 146(2):341-5. PubMed ID: 24939061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated partial breast irradiation for pure ductal carcinoma in situ.
    Park SS; Grills IS; Chen PY; Kestin LL; Ghilezan MI; Wallace M; Martinez AM; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):403-8. PubMed ID: 20800374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.